Analysis and Commentary STEVEN GROSSMAN 11/16/15 Analysis and Commentary STEVEN GROSSMAN 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Not Too Late to Write Appropriators to Increase FY 16 Funding for the FDA and more Read More Analysis and Commentary STEVEN GROSSMAN 11/6/15 Analysis and Commentary STEVEN GROSSMAN 11/6/15 The Clock Is Ticking; Act Now Please! Read More Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Please Send Us Your Letter in Support of FDA Funding and more Read More Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More Advocacy at a Glance STEVEN GROSSMAN 10/30/15 Advocacy at a Glance STEVEN GROSSMAN 10/30/15 How Does the Budget Deal Impact FDA’s Appropriations and more Read More Uncategorized STEVEN GROSSMAN 10/28/15 Uncategorized STEVEN GROSSMAN 10/28/15 A Potential Budget Deal Is in Place Read More Analysis and Commentary STEVEN GROSSMAN 10/23/15 Analysis and Commentary STEVEN GROSSMAN 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More Advocacy at a Glance STEVEN GROSSMAN 10/23/15 Advocacy at a Glance STEVEN GROSSMAN 10/23/15 FDA’s Center for Devices and Radiological Health Updates Regulatory Science Agenda and more Read More Analysis and Commentary STEVEN GROSSMAN 10/16/15 Analysis and Commentary STEVEN GROSSMAN 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Combination Products: an Expanding Area of FDA Responsibility and more Read More Analysis and Commentary STEVEN GROSSMAN 10/9/15 Analysis and Commentary STEVEN GROSSMAN 10/9/15 Turmoil at the Top of the Hill Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Will FSMA Make a Difference and more Read More Analysis and Commentary STEVEN GROSSMAN 10/2/15 Analysis and Commentary STEVEN GROSSMAN 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More Advocacy at a Glance STEVEN GROSSMAN 10/2/15 Advocacy at a Glance STEVEN GROSSMAN 10/2/15 DA Science Board Report Calls for Funding to Meet Responsibilities and more Read More Uncategorized STEVEN GROSSMAN 9/28/15 Uncategorized STEVEN GROSSMAN 9/28/15 Alliance Praises New FDA Science Board Report Read More Analysis and Commentary STEVEN GROSSMAN 9/25/15 Analysis and Commentary STEVEN GROSSMAN 9/25/15 After the Pope, the End-Game Approacheth Read More Advocacy at a Glance STEVEN GROSSMAN 9/25/15 Advocacy at a Glance STEVEN GROSSMAN 9/25/15 Everything You Should Know About Government Shutdowns and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Another Week Down and Two to Go Read More Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Federal Spending Negotiations Continue as Fiscal Deadline Inches Closer and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 11/16/15 Analysis and Commentary STEVEN GROSSMAN 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More
Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Not Too Late to Write Appropriators to Increase FY 16 Funding for the FDA and more Read More
Analysis and Commentary STEVEN GROSSMAN 11/6/15 Analysis and Commentary STEVEN GROSSMAN 11/6/15 The Clock Is Ticking; Act Now Please! Read More
Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Please Send Us Your Letter in Support of FDA Funding and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More
Advocacy at a Glance STEVEN GROSSMAN 10/30/15 Advocacy at a Glance STEVEN GROSSMAN 10/30/15 How Does the Budget Deal Impact FDA’s Appropriations and more Read More
Uncategorized STEVEN GROSSMAN 10/28/15 Uncategorized STEVEN GROSSMAN 10/28/15 A Potential Budget Deal Is in Place Read More
Analysis and Commentary STEVEN GROSSMAN 10/23/15 Analysis and Commentary STEVEN GROSSMAN 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More
Advocacy at a Glance STEVEN GROSSMAN 10/23/15 Advocacy at a Glance STEVEN GROSSMAN 10/23/15 FDA’s Center for Devices and Radiological Health Updates Regulatory Science Agenda and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/16/15 Analysis and Commentary STEVEN GROSSMAN 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More
Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Combination Products: an Expanding Area of FDA Responsibility and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/9/15 Analysis and Commentary STEVEN GROSSMAN 10/9/15 Turmoil at the Top of the Hill Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Advocacy at a Glance STEVEN GROSSMAN 10/9/15 Will FSMA Make a Difference and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/2/15 Analysis and Commentary STEVEN GROSSMAN 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More
Advocacy at a Glance STEVEN GROSSMAN 10/2/15 Advocacy at a Glance STEVEN GROSSMAN 10/2/15 DA Science Board Report Calls for Funding to Meet Responsibilities and more Read More
Uncategorized STEVEN GROSSMAN 9/28/15 Uncategorized STEVEN GROSSMAN 9/28/15 Alliance Praises New FDA Science Board Report Read More
Analysis and Commentary STEVEN GROSSMAN 9/25/15 Analysis and Commentary STEVEN GROSSMAN 9/25/15 After the Pope, the End-Game Approacheth Read More
Advocacy at a Glance STEVEN GROSSMAN 9/25/15 Advocacy at a Glance STEVEN GROSSMAN 9/25/15 Everything You Should Know About Government Shutdowns and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Another Week Down and Two to Go Read More
Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Advocacy at a Glance STEVEN GROSSMAN 9/18/15 Federal Spending Negotiations Continue as Fiscal Deadline Inches Closer and more Read More
